title: A 2-year, open-label pilot study of adjunctive chromium in patients with treatment-resistant rapid-cycling bipolar disorder.
authors.forename: Benedikt L
authors.initials: BL
authors.lastname: Amann
authors.forename: Roland
authors.initials: R
authors.lastname: Mergl
authors.forename: Eduard
authors.initials: E
authors.lastname: Vieta
authors.forename: Christoph
authors.initials: C
authors.lastname: Born
authors.forename: Igor
authors.initials: I
authors.lastname: Hermisson
authors.forename: Florian
authors.initials: F
authors.lastname: Seemueller
authors.forename: Sandra
authors.initials: S
authors.lastname: Dittmann
authors.forename: Heinz
authors.initials: H
authors.lastname: Grunze
mesh_terms: D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002712:Chlorides / Q000008:administration & dosage*; D017608:Chromium Compounds / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects
chemical_list: D000975:Antioxidants; D002712:Chlorides; D017608:Chromium Compounds; C017133:chromous chloride